GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above | Antibodies | News Channels - PipelineReview.com

GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above | Antibodies | News Channels  PipelineReview.com

GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above.